# IMPACT2 (NCT02152254)

> Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02152254
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Metastatic Malignant Neoplasm; Recurrent Malignant Neoplasm
- Interventions: Targeted Therapy Based on Molecular Profiling; Standard-of-Care Therapy
- Enrollment: 1362
- Primary outcome: Comparison of Progression-Free Survival (PFS) Between the Two Randomized Arms

## Indexed commentary on IMPACT2 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 6

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=impact2-nct02152254